UniProt ID | PLCD3_HUMAN | |
---|---|---|
UniProt AC | Q8N3E9 | |
Protein Name | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-3 | |
Gene Name | PLCD3 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 789 | |
Subcellular Localization |
Membrane Peripheral membrane protein. Cytoplasm. Cleavage furrow. Localizes at the cleavage furrow during cytokinesis. |
|
Protein Description | Hydrolyzes the phosphatidylinositol 4,5-bisphosphate (PIP2) to generate 2 second messenger molecules diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3). DAG mediates the activation of protein kinase C (PKC), while IP3 releases Ca(2+) from intracellular stores. Essential for trophoblast and placental development. May participate in cytokinesis by hydrolyzing PIP2 at the cleavage furrow.. | |
Protein Sequence | MLCGRWRRCRRPPEEPPVAAQVAAQVAAPVALPSPPTPSDGGTKRPGLRALKKMGLTEDEDVRAMLRGSRLRKIRSRTWHKERLYRLQEDGLSVWFQRRIPRAPSQHIFFVQHIEAVREGHQSEGLRRFGGAFAPARCLTIAFKGRRKNLDLAAPTAEEAQRWVRGLTKLRARLDAMSQRERLDHWIHSYLHRADSNQDSKMSFKEIKSLLRMVNVDMNDMYAYLLFKECDHSNNDRLEGAEIEEFLRRLLKRPELEEIFHQYSGEDRVLSAPELLEFLEDQGEEGATLARAQQLIQTYELNETAKQHELMTLDGFMMYLLSPEGAALDNTHTCVFQDMNQPLAHYFISSSHNTYLTDSQIGGPSSTEAYVRAFAQGCRCVELDCWEGPGGEPVIYHGHTLTSKILFRDVVQAVRDHAFTLSPYPVILSLENHCGLEQQAAMARHLCTILGDMLVTQALDSPNPEELPSPEQLKGRVLVKGKKLPAARSEDGRALSDREEEEEDDEEEEEEVEAAAQRRLAKQISPELSALAVYCHATRLRTLHPAPNAPQPCQVSSLSERKAKKLIREAGNSFVRHNARQLTRVYPLGLRMNSANYSPQEMWNSGCQLVALNFQTPGYEMDLNAGRFLVNGQCGYVLKPACLRQPDSTFDPEYPGPPRTTLSIQVLTAQQLPKLNAEKPHSIVDPLVRIEIHGVPADCARQETDYVLNNGFNPRWGQTLQFQLRAPELALVRFVVEDYDATSPNDFVGQFTLPLSSLKQGYRHIHLLSKDGASLSPATLFIQIRIQRS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
34 | Phosphorylation | AAPVALPSPPTPSDG HCCCCCCCCCCCCCC | 44.34 | 30266825 | |
37 | Phosphorylation | VALPSPPTPSDGGTK CCCCCCCCCCCCCCC | 38.52 | 25849741 | |
39 | Phosphorylation | LPSPPTPSDGGTKRP CCCCCCCCCCCCCCC | 51.90 | 30266825 | |
43 | Phosphorylation | PTPSDGGTKRPGLRA CCCCCCCCCCCCHHH | 29.43 | 30266825 | |
53 | Ubiquitination | PGLRALKKMGLTEDE CCHHHHHHCCCCCCH | 38.76 | 29967540 | |
105 | Phosphorylation | RRIPRAPSQHIFFVQ CCCCCCCCCCEEEEE | 33.15 | 30266825 | |
148 | Ubiquitination | IAFKGRRKNLDLAAP EEECCCCCCCCCCCC | 61.57 | 29967540 | |
200 | Phosphorylation | RADSNQDSKMSFKEI HHCCCCCCCCCHHHH | 22.09 | 20166139 | |
201 | Ubiquitination | ADSNQDSKMSFKEIK HCCCCCCCCCHHHHH | 47.02 | 33845483 | |
205 | Ubiquitination | QDSKMSFKEIKSLLR CCCCCCHHHHHHHHH | 51.74 | 33845483 | |
209 | Phosphorylation | MSFKEIKSLLRMVNV CCHHHHHHHHHHHCC | 37.99 | 24719451 | |
222 | Phosphorylation | NVDMNDMYAYLLFKE CCCHHHHHHHHHHHH | 8.58 | 29759185 | |
224 | Phosphorylation | DMNDMYAYLLFKECD CHHHHHHHHHHHHCC | 6.10 | 29759185 | |
252 | Ubiquitination | EFLRRLLKRPELEEI HHHHHHHCCHHHHHH | 71.19 | 29967540 | |
396 | Phosphorylation | PGGEPVIYHGHTLTS CCCCCEEEECCCCHH | 11.28 | - | |
489 | Phosphorylation | KKLPAARSEDGRALS CCCCCCCCCCCCCCC | 35.00 | 30576142 | |
496 | Phosphorylation | SEDGRALSDREEEEE CCCCCCCCCCCHHCC | 33.37 | 22167270 | |
534 | Phosphorylation | ELSALAVYCHATRLR HHHHHHHHHHHHCCC | 3.49 | 27642862 | |
542 | Phosphorylation | CHATRLRTLHPAPNA HHHHCCCCCCCCCCC | 33.73 | 23312004 | |
556 | Phosphorylation | APQPCQVSSLSERKA CCCCCCCCCCCHHHH | 10.32 | 23663014 | |
557 | Phosphorylation | PQPCQVSSLSERKAK CCCCCCCCCCHHHHH | 36.74 | 22167270 | |
559 | Phosphorylation | PCQVSSLSERKAKKL CCCCCCCCHHHHHHH | 36.98 | 23663014 | |
573 | Phosphorylation | LIREAGNSFVRHNAR HHHHHHHHHHHCCHH | 24.97 | 30266825 | |
583 | Phosphorylation | RHNARQLTRVYPLGL HCCHHHHCEEEECCC | 15.11 | - | |
679 | Ubiquitination | LPKLNAEKPHSIVDP CCCCCCCCCCCCCCC | 45.69 | 33845483 | |
704 | Phosphorylation | ADCARQETDYVLNNG HHHHHHCCCEECCCC | 25.05 | 28102081 | |
706 | Phosphorylation | CARQETDYVLNNGFN HHHHCCCEECCCCCC | 17.79 | 24927040 | |
742 | Phosphorylation | VVEDYDATSPNDFVG EEECCCCCCCCCCCE | 41.65 | - | |
756 | Phosphorylation | GQFTLPLSSLKQGYR EEEEEEHHHHCCCCC | 31.52 | 24719451 | |
759 | Ubiquitination | TLPLSSLKQGYRHIH EEEHHHHCCCCCEEE | 43.56 | 21906983 | |
779 | Phosphorylation | GASLSPATLFIQIRI CCCCCCEEEEEEEEE | 26.11 | 22210691 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PLCD3_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PLCD3_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PLCD3_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
Oops, there are no PPI records of PLCD3_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-105 AND SER-496, ANDMASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-496, AND MASSSPECTROMETRY. |